| Expression pattern: |
DN |
| Associated gene: |
DAB2IP |
| Associated microRNA: |
miR-328-5p |
| Biological function: |
tumor suppressor; attenuates malignant behaviors (proliferation, wound healing/migration, invasion) and promotes apoptosis; inhibits EMT; suppresses xenograft tumor growth |
| Molecular mechanism: |
ceRNA sponging miR-328-5p to de-repress DAB2IP; associated with decreased DAB2IP promoter methylation in xenograft tumors |
| Biological pathway or process: |
proliferation (inhibits); migration (inhibits); invasion (inhibits); apoptosis (promotes); EMT (inhibits); ceRNA regulation (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; Bioinformatics Analysis; RT-qPCR; Luciferase Reporter Assay; Transfection; MTT; Wound Healing Assay; Transwell Assay; Annexin V/PI Flow Cytometry; Western Blot; MSP (Methylation-Specific PCR); In Vivo Animal Model; Clinical Sample Validation |
| Clinical significance: |
lower circRNA-5692 expression was significantly associated with abnormal higher levels of AFP, cirrhosis history, larger tumor size, and distant metastasis |
| Description: |
circRNA-5692 is down-regulated in hepatocellular carcinoma and functions as a tumor suppressor. It inhibits proliferation, migration/wound healing, invasion, EMT, and xenograft tumor growth while promoting apoptosis, mainly by sponging miR-328-5p to increase DAB2IP expression. |
| Confidence score: |
0.73 |